“…A prevalence of hepatitis C antibodies of 12% in hemodialysis patients as found in the total sample in our region is of the same order as reported from other parts of western Europe, the United States, and Japan [Esteban et al, 1989;Gilli et al, 1990;Jeffers et al, 1990;Hayashi et al, 19911. There is, however, considerable variation among the units, where from zero to 22% of the patients show antibodies against HCV.…”